• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

物质使用障碍作为血管性水肿患者插管的危险因素:一项全国性队列研究。

Substance Use Disorder as Risk Factor for Intubation in Angioedema: A Nationwide Cohort Study.

作者信息

Bogart Joseph, Otteson Todd

机构信息

Case Western Reserve University School of Medicine, Cleveland, Ohio, U.S.A.

Department of Otolaryngology-Head and Neck Surgery, University Hospitals Cleveland Medical Center, Cleveland, Ohio, U.S.A.

出版信息

Laryngoscope. 2025 Jan;135(1):45-49. doi: 10.1002/lary.31644. Epub 2024 Jul 15.

DOI:10.1002/lary.31644
PMID:39007365
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11635145/
Abstract

OBJECTIVES

Individuals with angioedema (AE) are at high risk for airway compromise and often require endotracheal intubation. Patient factors predisposing one to airway compromise are not well described. The objective of this study is to examine whether substance use disorder (SUD) in patients with AE is associated with need for airway intervention.

METHODS

This population-based retrospective cohort study compared AE patients with SUD versus propensity-matched control groups. Outcomes were hospitalization, intubation, and tracheotomy. Using the TriNetX National Database, this study included 28,931 patients with SUD and 117,509 patients without SUD who presented with AE.

RESULTS

Among patients with AE, those with each subtype of SUD (alcohol, cannabis, cocaine, tobacco, and opioids) were found to have higher risk of severe AE compared to propensity-matched non-SUD cohorts. Rate of hospitalization after cohort matching ranged from 20.4% for tobacco use disorder to 30.4% for cocaine use disorder, all significantly higher than the 8.0% in a population without SUD. Each SUD subtype was associated with a higher rate of intubation compared with matched non-SUD groups, with cannabis use disorder having the highest relative risk (RR) of 3.67 (95% CI: 2.69-5.02). Tobacco (RR = 2.45, 95% CI: 1.79-3.34) and alcohol (RR = 2.82, 95% CI: 1.73-4.58) use disorders were both associated with significantly higher risk of tracheotomy.

CONCLUSION

These data suggest that patients with SUD, regardless of subtype, and after propensity matching for demographics and comorbidities are at higher risk for adverse outcomes when presenting with AE. This study highlights clinically relevant predictors of airway compromise.

LEVEL OF EVIDENCE

3 Laryngoscope, 135:45-49, 2025.

摘要

目的

血管性水肿(AE)患者气道梗阻风险高,常需气管插管。导致气道梗阻的患者因素尚无充分描述。本研究的目的是探讨AE患者的物质使用障碍(SUD)是否与气道干预需求相关。

方法

这项基于人群的回顾性队列研究将患有SUD的AE患者与倾向匹配的对照组进行比较。结局指标为住院、插管和气管切开术。利用TriNetX国家数据库,本研究纳入了28931例患有SUD的患者和117509例未患SUD且出现AE的患者。

结果

在AE患者中,与倾向匹配的非SUD队列相比,每种SUD亚型(酒精、大麻、可卡因、烟草和阿片类药物)的患者发生严重AE的风险更高。队列匹配后的住院率从烟草使用障碍患者的20.4%到可卡因使用障碍患者的30.4%不等,均显著高于无SUD人群的8.0%。与匹配的非SUD组相比,每种SUD亚型的插管率均较高,大麻使用障碍的相对风险(RR)最高,为3.67(95%CI:2.69 - 5.02)。烟草(RR = 2.45,95%CI:1.79 - 3.34)和酒精(RR = 2.82,95%CI:1.73 - 4.58)使用障碍均与气管切开术的显著更高风险相关。

结论

这些数据表明,SUD患者无论亚型如何,在进行人口统计学和合并症倾向匹配后,出现AE时不良结局风险更高。本研究突出了气道梗阻的临床相关预测因素。

证据水平

3《喉镜》,135:45 - 49,2025年。

相似文献

1
Substance Use Disorder as Risk Factor for Intubation in Angioedema: A Nationwide Cohort Study.物质使用障碍作为血管性水肿患者插管的危险因素:一项全国性队列研究。
Laryngoscope. 2025 Jan;135(1):45-49. doi: 10.1002/lary.31644. Epub 2024 Jul 15.
2
Increased risk for COVID-19 breakthrough infection in fully vaccinated patients with substance use disorders in the United States between December 2020 and August 2021.2020年12月至2021年8月期间,美国患有物质使用障碍的完全接种疫苗患者感染新冠病毒突破性感染的风险增加。
World Psychiatry. 2022 Feb;21(1):124-132. doi: 10.1002/wps.20921. Epub 2021 Oct 5.
3
Impact of Cannabis Use, Substance Use Disorders, and Psychiatric Diagnoses on COVID-19 Outcomes: A Retrospective Cohort Study.大麻使用、物质使用障碍和精神诊断对 COVID-19 结局的影响:一项回顾性队列研究。
J Clin Psychiatry. 2022 Aug 29;83(5):21m14332. doi: 10.4088/JCP.21m14332.
4
Medical complications associated with substance use disorders in patients with type 2 diabetes and hypertension: electronic health record findings.与 2 型糖尿病和高血压患者物质使用障碍相关的医疗并发症:电子健康记录发现。
Addiction. 2019 Aug;114(8):1462-1470. doi: 10.1111/add.14607. Epub 2019 Apr 25.
5
The burden of angioedema on United States emergency departments: 2006-2010.2006 - 2010年血管性水肿给美国急诊科带来的负担
Laryngoscope. 2017 Apr;127(4):828-834. doi: 10.1002/lary.26336. Epub 2016 Nov 15.
6
Inpatient Addiction Medicine Consultation and Post-Hospital Substance Use Disorder Treatment Engagement: a Propensity-Matched Analysis.住院成瘾医学咨询和出院后物质使用障碍治疗参与度:倾向评分匹配分析。
J Gen Intern Med. 2019 Dec;34(12):2796-2803. doi: 10.1007/s11606-019-05251-9.
7
Hospitalization Associated With Comorbid Psychiatric and Substance Use Disorders Among Adults With COVID-19 Treated in US Emergency Departments From April 2020 to August 2021.2020 年 4 月至 2021 年 8 月期间,美国急诊科治疗的 COVID-19 成年患者合并精神和物质使用障碍的住院情况。
JAMA Psychiatry. 2023 Apr 1;80(4):331-341. doi: 10.1001/jamapsychiatry.2022.5047.
8
The trajectory of substance use disorder among people formerly in foster care: A survival analysis.曾在寄养机构生活的人群中物质使用障碍的轨迹:一项生存分析。
Int J Soc Psychiatry. 2025 Feb;71(1):159-167. doi: 10.1177/00207640241287088. Epub 2024 Oct 25.
9
Clinical effectiveness of nirmatrelvir plus ritonavir in patients with COVID-19 and substance use disorders based on real-world data.基于真实世界数据的奈玛特韦/利托那韦治疗 COVID-19 合并物质使用障碍患者的临床效果。
J Med Virol. 2023 May;95(5):e28801. doi: 10.1002/jmv.28801.
10
Tracheotomy versus endotracheal intubation for airway management in deep neck space infections.在深部颈部间隙感染的气道管理中,气管切开术与气管插管的比较
J Oral Maxillofac Surg. 2002 Apr;60(4):349-54; discussion 354-5. doi: 10.1053/joms.2002.31218.

本文引用的文献

1
Bradykinin Metabolism and Drug-Induced Angioedema.缓激肽代谢与药物性血管性水肿。
Int J Mol Sci. 2023 Jul 19;24(14):11649. doi: 10.3390/ijms241411649.
2
Concomitant medication in patients with bradykinin-mediated angioedema - there's more than ACE inhibitors.伴有缓激肽介导血管性水肿患者的伴随药物治疗——不仅仅是 ACE 抑制剂。
J Dtsch Dermatol Ges. 2023 Nov;21(11):1283-1289. doi: 10.1111/ddg.15154. Epub 2023 Jul 23.
3
Inflammatory Biomarkers in Addictive Disorders.成瘾障碍中的炎症生物标志物。
Biomolecules. 2021 Dec 3;11(12):1824. doi: 10.3390/biom11121824.
4
MRGPRX2 and Adverse Drug Reactions.MRGPRX2 与药物不良反应。
Front Immunol. 2021 Aug 6;12:676354. doi: 10.3389/fimmu.2021.676354. eCollection 2021.
5
Incidence and risk factors of angiotensin-converting enzyme inhibitor-induced angioedema: A large case-control study.血管紧张素转换酶抑制剂所致血管性水肿的发病率及危险因素:一项大型病例对照研究。
Ann Allergy Asthma Immunol. 2021 Nov;127(5):591-592. doi: 10.1016/j.anai.2021.07.028. Epub 2021 Aug 4.
6
Angioedema-related emergency department visits in the United States: Epidemiology and time trends, 2006-2015.2006 - 2015年美国血管性水肿相关的急诊科就诊情况:流行病学与时间趋势
J Allergy Clin Immunol Pract. 2020 Jul-Aug;8(7):2442-2444. doi: 10.1016/j.jaip.2020.03.046. Epub 2020 Apr 14.
7
ACE inhibitor-mediated angioedema.血管紧张素转换酶抑制剂相关性血管水肿。
Int Immunopharmacol. 2020 Jan;78:106081. doi: 10.1016/j.intimp.2019.106081. Epub 2019 Dec 10.
8
Evaluation and Management of Angioedema in the Emergency Department.急诊科血管性水肿的评估与管理。
West J Emerg Med. 2019 Jul;20(4):587-600. doi: 10.5811/westjem.2019.5.42650. Epub 2019 Jul 2.
9
Trends in hospitalizations related to anaphylaxis, angioedema, and urticaria in the United States.美国与过敏反应、血管性水肿和荨麻疹相关的住院治疗趋势。
Ann Allergy Asthma Immunol. 2019 Apr;122(4):401-406.e2. doi: 10.1016/j.anai.2019.02.003. Epub 2019 Feb 13.
10
ACE Inhibitor-Induced Angioedema: a Review.血管紧张素转换酶抑制剂相关性血管水肿:综述。
Curr Hypertens Rep. 2018 Jun 8;20(7):55. doi: 10.1007/s11906-018-0859-x.